Skip to content

Author

Weijiang Lin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

UCEC: A Knowledge Graph-Assisted Machine Learning for Molecular-Mechanism-Interpretable Natural Product-Disease Association Prioritization.

A knowledge graph-assisted machine learning model: Uncertainty-Calibrated Evidence-Chains (UCEC) for prioritizing NP-disease associations and generating traceable mechanistic hypotheses for subsequent validation is proposed.

Wen-Yu Lu, Yi-Hui Cai, Xiao-Qian Peng et al. · 0 citations
Aug 2026

Arglabin targets a non-canonical NLRP3/CCR2 axis to suppress MDSC infiltration and potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma.

It is demonstrated that Arg suppresses HCC progression in syngeneic murine models by reducing MDSC infiltration and promoting CD8+ T-cell accumulation, providing a strategy for reversing immunosuppression and potentiating immunotherapy.

Di Kang, Jun-Yuan Duan, Qi Lv et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.